Surgi

Jerusalem, IsraelFounded 20231–10 employeessurgi.aiLinkedIn

Surgi develops an AI-powered surgical guidance platform that turns preoperative images into real-time anatomical insights during surgery. Its technology tracks changing soft tissue and aligns live anatomy with preoperative data to support more precise decisions and improve surgical safety.

Visit surgi.ai ↗

Founded: 2023
Employees: 1–10

reccy insights

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

Recent highlights

SurgiAI’s available milestones point to early development of an AI-based surgical guidance approach rather than a documented sequence of commercial launches. The company was founded in 2023 and received non-equity assistance on Jul 2, 2024, with MassChallenge Israel identified as the lead investor for that activity. The two funding descriptions differ in type, date, and named investors, so they should not be treated as a single confirmed transaction. SurgiAI describes technology that detects and segments anatomical structures in real time, while its product materials emphasize tracking soft-tissue movement and aligning live anatomy with preoperative images. The clearest milestone is therefore the combination of early-stage funding activity and a defined technical focus on intraoperative anatomical guidance.

Market position

SurgiAI operates in medical technology, applying computer vision and artificial intelligence to intraoperative guidance. Its described approach combines a 3D camera, real-time anatomical detection and segmentation, soft-tissue tracking, and alignment of live anatomy with preoperative images. That focus addresses a limitation of workflows that rely on static preoperative imaging when anatomy changes during an operation. The company says its technology is designed to fit existing surgical workflows with minimal adaptation, but there is no evidence here establishing clinical adoption, regulatory clearance, or comparative performance. SurgiAI remains an early-stage, small-team company: it was founded in 2023, has an employee range of 1–10, and has a reported $800,000 Seed round alongside a separately described non-equity assistance activity. Its differentiation is currently best characterized by its emphasis on updating anatomical guidance as soft tissue shifts, rather than by demonstrated market share or clinical outcomes.

Growth & opportunities

SurgiAI’s growth signals describe an early-stage company building a focused surgical-imaging product, with limited evidence of commercial scale. Founded in 2023 in Jerusalem, it is listed in the 1–10 employee range and has no reported hiring news or recent layoffs. Funding information indicates two distinct activities: non-equity assistance dated Jul 2, 2024, with MassChallenge Israel as lead investor, and a $800,000 Seed round described as occurring in September 2024, involving eHealthVentures and the Israel Innovation Authority. Because the round types, dates, and investors do not align, the funding history needs clarification; the September date lacks a specific day. The technical proposition is more clearly defined than the company’s go-to-market progress: SurgiAI describes real-time anatomical segmentation, 3D-camera-based soft-tissue tracking, and alignment of live anatomy with preoperative images. The funding activity and technical focus are meaningful early milestones, while available evidence is insufficient to establish a subsequent acceleration in hiring, adoption, or revenue.

Written by reccy's AI from company sites, press and funding records · updated Oct 2026

What makes Surgi distinct

reccy insights

What makes Surgi distinct

01Provides continuously updated anatomical insights as soft tissue shifts during surgery, rather than relying only on static preoperative images.
02Uses a 3D camera and proprietary AI to detect and segment anatomical structures in real time.
03Aligns preoperative images with the patient’s live anatomy during a procedure.
04Is designed to integrate into existing surgical workflows with minimal adaptation.
05Targets improved surgical precision and decision support in complex procedures.

Technology & products

AI-powered surgical guidance platform
Uses real-time anatomical detection and segmentation to track soft-tissue changes and align live anatomy with preoperative images during surgery.

AI-powered real-time surgical guidance platform.
3D-camera-based soft-tissue tracking and characterization.
Proprietary AI algorithms for anatomical structure detection and segmentation.
Technology for aligning preoperative images with real-time patient anatomy.

About Surgi

Products: AI-powered surgical guidance platform
Focus areas: NeuroTechnology, medical devices, digital health, AI/ML, health care, medical, surgical technology, surgical guidance
Headquarters: Jerusalem, Israel
Founded: 2023
Employees: 1–10
Patents granted: 1 (Crunchbase)